AstraZeneca PLC (NASDAQ:AZN)
| 54.93 Delayed Data As of 4:00pm ET |  +0.24 / +0.44%Today’s Change | 52.65 Today|||52-Week Range 71.70 | -5.70% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 54.69 |
| Today’s open | 54.74 |
| Day’s range | 54.28 - 55.03 |
| Volume | 520,852 |
| Average volume (3 months) | 6,509,562 |
| Market cap | $169.2B |
Data as of 4:00pm ET, 09/29/2022
Growth & Valuation
| Earnings growth (last year) | -96.76% |
| Earnings growth (this year) | +25.27% |
| Earnings growth (next 5 years) | +15.85% |
| Revenue growth (last year) | +37.11% |
| P/E ratio | NM |
| Price/Sales | 4.39 |
| Price/Book | 4.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.23 | +0.30% |
| NVONovo Nordisk | +1.09 | +1.10% |
| BMYBristol-Myers Squibb | -0.35 | -0.49% |
| MRKMerck | -0.08 | -0.09% |
Data as of 4:00pm ET, 09/29/2022
Financials
| Next reporting date | November 10, 2022 |
| EPS forecast (this quarter) | $0.77 |
| Annual revenue (last year) | $37.8B |
| Annual profit (last year) | $112.0M |
| Net profit margin | 0.30% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
